896 related articles for article (PubMed ID: 9209737)
1. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
[TBL] [Abstract][Full Text] [Related]
2. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
[TBL] [Abstract][Full Text] [Related]
3. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
[TBL] [Abstract][Full Text] [Related]
6. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia.
Viollier R; Passweg J; Gregor M; Favre G; Kühne T; Nissen C; Gratwohl A; Tichelli A
Ann Hematol; 2005 Jan; 84(1):47-55. PubMed ID: 15340760
[TBL] [Abstract][Full Text] [Related]
7. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting.
Gustafsson A; Remberger M; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 May; 25(10):1059-65. PubMed ID: 10828866
[TBL] [Abstract][Full Text] [Related]
8. CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo FJ; Cabrera R; Sanz MA; Petit J; Bueno J; Maldonado J; Odriozola J; Conde JG; Brunet S; Carreras E; Iriondo A; Fernández-Rañada JM; Marín P;
Bone Marrow Transplant; 2002 Feb; 29(3):205-11. PubMed ID: 11859392
[TBL] [Abstract][Full Text] [Related]
9. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
10. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM
Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
13. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
[TBL] [Abstract][Full Text] [Related]
14. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
[TBL] [Abstract][Full Text] [Related]
15. Improved survival in severe acquired aplastic anemia of childhood.
Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
[TBL] [Abstract][Full Text] [Related]
16. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
[TBL] [Abstract][Full Text] [Related]
17. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
Osugi Y; Yagasaki H; Sako M; Kosaka Y; Taga T; Ito T; Yamamoto M; Ohara A; Sato T; Mimaya J; Tsukimoto I; Kojima S;
Haematologica; 2007 Dec; 92(12):1687-90. PubMed ID: 18055993
[TBL] [Abstract][Full Text] [Related]
18. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
Bunin N; Aplenc R; Iannone R; Leahey A; Grupp S; Monos D; Pierson G
Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818
[TBL] [Abstract][Full Text] [Related]
19. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH
Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies for patients with severe aplastic anemia.
Bacigalupo A
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S42-S44. PubMed ID: 18724299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
